15-27789763-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000275.3(OCA2):c.2433-34291G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 151,970 control chromosomes in the GnomAD database, including 6,901 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.28   (  6901   hom.,  cov: 33) 
Consequence
 OCA2
NM_000275.3 intron
NM_000275.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.429  
Publications
2 publications found 
Genes affected
 OCA2  (HGNC:8101):  (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014] 
OCA2 Gene-Disease associations (from GenCC):
- oculocutaneous albinism type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.365  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.277  AC: 42096AN: 151852Hom.:  6898  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
42096
AN: 
151852
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.277  AC: 42118AN: 151970Hom.:  6901  Cov.: 33 AF XY:  0.271  AC XY: 20094AN XY: 74264 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
42118
AN: 
151970
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
20094
AN XY: 
74264
show subpopulations 
African (AFR) 
 AF: 
AC: 
7299
AN: 
41440
American (AMR) 
 AF: 
AC: 
3174
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
873
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
6
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
520
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
4401
AN: 
10500
Middle Eastern (MID) 
 AF: 
AC: 
53
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
25099
AN: 
67966
Other (OTH) 
 AF: 
AC: 
470
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1525 
 3050 
 4575 
 6100 
 7625 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 414 
 828 
 1242 
 1656 
 2070 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
221
AN: 
3476
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.